Viewing Study NCT05609994


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-01-21 @ 11:51 PM
Study NCT ID: NCT05609994
Status: RECRUITING
Last Update Posted: 2025-07-18
First Post: 2022-11-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Sponsor: Katy Peters, MD, PhD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module